Point72

Activity from announced rounds

All recorded activity
Rounds participated in
4
Confirmed lead rounds
0
1 roles undisclosed
New companies
3
First participation on record · 1 follow-on
Funding in participating rounds
$4.4B
4 disclosed · full round size, not this investor’s share

By stage

Series B3
Series C+1

By primary sector

AI2
Biotech1
Climate tech1

By country

United Kingdom2
United States2

Rounds

4 in all activity
Valar Atomics

Valar Atomics develops modular nuclear reactors and energy campuses for industrial heat and electricity.

$1BSeries B
Participant
Nscale

Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference

$2BSeries C
Participant
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries B
Role not disclosed
Nscale

Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference

$1.1BSeries B
Participant